Invesco
CTKB icon

Invesco’s Cytek Biosciences CTKB Stock Holding History

Invesco’s Portfolio CTKB Stock Details CTKB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.7M Sell
388,233
-10,564
-3% -$49.9K ﹤0.01% 2611
2025
Q4 		$2.01M Buy
398,797
+9,671
+2% +$44.9K ﹤0.01% 2605
2025
Q3 		$1.35M Buy
389,126
+45,467
+13% +$171K ﹤0.01% 2788
2025
Q2 		$1.17M Buy
343,659
+6,706
+2% +$22.3K ﹤0.01% 2782
2025
Q1 		$1.35M Buy
336,953
+9,893
+3% +$51.3K ﹤0.01% 2708
2024
Q4 		$2.12M Sell
327,060
-5,845
-2% -$34.8K ﹤0.01% 2595
2024
Q3 		$1.84M Buy
332,905
+12,434
+4% +$70.5K ﹤0.01% 2641
2024
Q2 		$1.79M Sell
320,471
-31,373
-9% -$188K ﹤0.01% 2628
2024
Q1 		$2.36M Buy
351,844
+26,235
+8% +$208K ﹤0.01% 2578
2023
Q4 		$2.97M Sell
325,609
-66,082
-17% -$416K ﹤0.01% 2472
2023
Q3 		$2.16M Buy
391,691
+19,145
+5% +$154K ﹤0.01% 2567
2023
Q2 		$3.18M Buy
372,546
+250,243
+205% +$2.24M ﹤0.01% 2460
2023
Q1 		$1.12M Buy
122,303
+73,992
+153% +$796K ﹤0.01% 2856
2022
Q4 		$493K Sell
48,311
-4,766
-9% -$64.1K ﹤0.01% 3273
2022
Q3 		$781K Buy
53,077
+416
+0.8% +$5.4K ﹤0.01% 3021
2022
Q2 		$565K Buy
52,661
+12,561
+31% +$125K ﹤0.01% 3271
2022
Q1 		$432K Buy
+40,100
New +$542K ﹤0.01% 3469

Other funds holding CTKB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCM
Topline Capital Management Santa Monica, California $605M AUM 26.24% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Invesco's CTKB Position: Q1 2026 in Review

Invesco reduced its Cytek Biosciences (CTKB) stake by 2.6% in Q1 2026, selling an estimated $49.9K and leaving 388,233 shares worth $1.7M. The position accounts for ﹤0.01% of the portfolio, ranked #2611.

Invesco first reported a position in CTKB in Q1 2022 and has held it in 17 quarters since. The position peaked at $3.18M in Q2 2023. 165 funds tracked by Wall St. Rank hold CTKB as of Q1 2026.

  • Invesco held 388,233 shares of Cytek Biosciences worth $1.7M as of Q1 2026.
  • Invesco sold 10,564 Cytek Biosciences shares in Q1 2026, an estimated $49.9K.
  • Cytek Biosciences made up ﹤0.01% of Invesco's portfolio in Q1 2026, its #2611 holding.
  • Invesco first reported a position in Cytek Biosciences in Q1 2022 and has held it in 17 quarters since.
  • Invesco's Cytek Biosciences position peaked at $3.18M in Q2 2023.
  • 165 funds tracked by Wall St. Rank held Cytek Biosciences as of Q1 2026.

Based on Invesco's 13F filing for Q1 2026, filed 12 May 2026.